Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Lilly reports encouraging trial results for its next-gen GLP-1 shot

Patients taking the highest dose of retatrutide lost 16.8% of their body weight after 40 weeks, more than its current bestseller, tirzepatide.

J. Edward Moreno
Author: J. Edward Moreno

Source: Sherwood News.

Written by

J. Edward Moreno

in

Business
←WATCH: Best friends of 50 years go viral after one shares cancer journey
21 Essential Books That Fiercely Celebrate Black Womanhood→

More posts

  • Maine Democrat Jackson acknowledges 1988 assault, denies pushing longtime partner 

  • Matt Creasey Becomes Senior EVP, World, At Post-Merger Banijay Rights

  • ‘Hope In The Water’ Docuseries From David E. Kelley & Andrew Zimmern Renewed For Season 2 At PBS

  • Consumers want to watch movies at Home. No lawsuit will change that.

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube